Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warm-yang TCM formula versus venlafaxine for depression in Parkinson's disease
ChiCTR-TRC-14005143Phase 2Recruiting
- Sponsor
- Third Affiliated Hospital, Beijing University of Chinese Medicine
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of wenyang jieyu formula granule and venlafaxine in depression in Parkinson's disease (2 arms), sponsored by Third Affiliated Hospital, Beijing University of Chinese Medicine. Primary endpoints: Hamilton Depression Scale and TCM Syndrome rating scale. Started Jun 2014; status: recruiting.
02
Drugs
wenyang jieyu formula granulevenlafaxine
03
Conditions
depression in Parkinson's disease
Beyond the preview
Go deeper on ChiCTR-TRC-14005143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005143.